Association Between Topical Calcineurin Inhibitor Use and Risk of Cancer, Including Lymphoma, Keratinocyte Carcinoma, and Melanoma: A Systematic Review and Meta-analysis

Analysis of 11 observational studies found no association between topical calcineurin inhibitor (TCI) use and risk of cancer overall or skin cancer, and although there was an elevated lymphoma risk, the absolute risk was low.

British Medical Journal